GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Interest Income

Control Bionics (ASX:CBL) Interest Income : A$0.01 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Control Bionics's interest income for the six months ended in Dec. 2023 was A$0.01 Mil. Its interest income for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.01 Mil.


Control Bionics Interest Income Historical Data

The historical data trend for Control Bionics's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics Interest Income Chart

Control Bionics Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Interest Income
- - - 0.02

Control Bionics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Interest Income Get a 7-Day Free Trial - - - - 0.01

Control Bionics Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Control Bionics (ASX:CBL) Business Description

Traded in Other Exchanges
N/A
Address
697 Bourke Road, Suite 5.01, Camberwell, Melbourne, VIC, AUS, 3124
Control Bionics Ltd is engaged in the business of healthcare devices. It is engaged in the development, commercialization, and sale of assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.